Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is an expert opinion piece articulating a conceptual framework for the evolution of theranostics from target discovery to integrated precision medicine, based on established evidence and clinical practice.
This is a mechanistic mini-review that synthesizes existing literature to propose integrin β1 as a candidate regulator of medulloblastoma progression, without presenting original experimental evidence or clinical data.